Table 1. Patient characteristics and proportions of CD133+ tumor cells.

No.	Organ site	AJCC stage	Pathology	Grade	Lymphatic invasion	Perineural invasion	Tumor budding	CD133 (%)	CD133/EPCAM
1	Colon	IIIB	Adenoca	MD	0	0	0	2.27	2.05
2	Colon	IIA	Adenoca	MD	0	0	0	1.03	0.77
3	Colon	IIIB	Adenoca	PD	+	0	+	0.97	0.88
4	Colon	IIIC	Adenoca	MD	+	+	+	1.21	1.05
5	Rectum	IIIB	Adenoca	MD	0	0	0	2.76	2.48
	Rectum	IIIA	Mucinous	–	0	0	0	0.96	0.62
6	Colon	I	Adenoca	MD	0	0	0	0.03	0.03
7	Colon	IIIB	Adenoca	MD	0	0	+	1.52	1.68
8	Rectum	IIIB	Adenoca	MD	+	0	+	7.10	6.86
9	Colon	IIA	Adenoca	MD	0	0	0	1.86	1.67
10	Lymph node	IV (LN)	Adenoca	MD	+	+	+	5.27	4.89
11	Colon	IV (liver)	Adenoca	MD	+	0	+	10.76	10.03
12	Colon	IIIB	Adenoca	MD	+	+	0	0.76	0.66
13	Colon	IIA	Adenoca	MD	0	0	0	0.25	0.21
14	Colon	IIIB	Adenoca	MD	+	0	+	2.08	2.01
15	Colon	IIIA	Adenoca	MD	0	0	0	1.80	1.75
16	Colon	I	Adenoca	MD	0	0	0	2.00	1.93
17	Colon	IIA	Mucinous		0	0	0	3.85	3.48
18	Colon	IIA	Adenoca	MD	0	0	0	3.67	3.38
19	Colon	IIIB	Adenoca	MD	0	0	+	1.09	1.01
20	Colon	IIIC	Adenoca	MD	+	0	+	1.37	1.12
21	Colon	IIA	Adenoca	MD	0	0	0	2.59	2.53
22	Colon	IIA	Adenoca	MD	0	0	0	2.78	2.64
23	Colon	IV	Adenoca	MD	+	0	+	3.74	3.49
	Peritoneal seeding	IV	Adenoca	MD	+	0	+	1.67	1.58
24	Colon	IIIB	Adenoca	MD	+	0	+	1.84	1.80
25	Colon	IV	Adenoca	MD	+	+	0	1.75	1.62
	Lymph node	IV	Adenoca	MD	+	+	0	3.81	3.53
26	Colon	IIC	Adenoca	MD	+	0	+	3.61	3.49
27	Colon	IIC	Adenoca	MD	0	0	0	7.92	7.40

MD, moderately differentiated.